These results are consistent with those of the current research; for example, isorhamnetin decreases the growth of gastric cancer via activating PPARγ (Ramachandran et al., 2012); Epigallocatechin-3-O-gallate via activation of PPARγ upregulates Pim-1 to protect the vascular (Liu et al., 2013); and morin attenuate synovial angiogenesis by activation of PPARγ (Yue et al., 2018). This evidence concerns the gene PIM1 and gastric cancer.